International Journal of Medical Science and Pharmaceutical Research

Background: Ophthalmic diseases cause significant morbidity globally, but comprehensive data from Gombe State, Northeastern Nigeria, remains limited. Understanding local disease patterns is essential for evidence-based healthcare planning and resource allocation.

Objective: To describe the pattern, distribution, and demographic associations of ophthalmic diseases among patients presenting to Specialist Hospital Gombe (SSHG).

Methods: A retrospective cross-sectional study of 9,200 patients attending the ophthalmology clinic at SSHG. Data on age, sex, primary diagnosis, presenting complaints, and treatment were analyzed using descriptive statistics, frequency distributions, cross-tabulations, and chi-square tests.

Results: The mean age was 28.4±20.2 years (median: 25.0). 42.3% were male and 57.7% female (M:F ratio 0.73:1). The five most common diagnoses were: Allergic Conjunctivitis (46.4%), Bacterial Conjunctivitis (11.8%), Refractive Error (9.7%), Cataract (8.3%), and Vernal Conjunctivitis (5.6%). There was a statistically significant association between age group and diagnosis (χ² = 3085.06, df = 168, p = 0.0000e+00). The most common presenting complaints were Itching (27.2%), Discharge (12.6%), and Redness (12.1%). Antibiotic eye drops were the most frequently prescribed treatment (27.7%).
Conclusion: Allergic Conjunctivitis is the leading diagnosis at SSHG (46.4%), followed by Bacterial Conjunctivitis and Refractive Error. Disease patterns vary significantly by age, supporting age-targeted interventions. The high rate of antibiotic prescriptions (27.7%) indicates a need for antimicrobial stewardship programs. These findings provide essential baseline data for eye care planning in Gombe State.

Ophthalmic diseases; disease pattern; epidemiology; Gombe; Nigeria; conjunctivitis; cataract; glaucoma; refractive errors

1. World Health Organization. World report on vision. Geneva: WHO; 2019.
2. Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment. Lancet Glob Health. 2017;5(9):e888-e897.
3. Kyari F, Abdull MM, Bastawrous A, et al. Epidemiology of blindness in Nigeria: the Nigeria National Blindness and Visual Impairment Survey. Niger J Clin Pract. 2019;22(11):1483-1492.
4. Abdull MM, Sivasubramaniam S, Murthy GV, et al. Causes of blindness and visual impairment in Nigeria. Invest Ophthalmol Vis Sci. 2015;56(8):4341-4350.
5. Gilbert CE, Murthy GV, Sivasubramaniam S, et al. Couching in Nigeria: prevalence, risk factors and visual acuity outcomes. Ophthalmic Epidemiol. 2011;18(6):269-275.
6. Owoeye JF, Adepoju FG, Akande TM, et al. The eye care workforce in Nigeria: a situational analysis. Niger J Med. 2017;26(2):124-130.
7. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. Lancet. 2007;370(9596):1453-1457.
8. Adepoju FG, Ayanniyi AA, Pam V, Aremu OO. Pattern of eye diseases in a university teaching hospital in north-central Nigeria. Niger J Med. 2012;21(4):381-385.
9. Bekibele CO, Ogunsola ET. Pattern of eye diseases in a Nigerian ophthalmic outpatient clinic. Niger J Clin Pract. 2014;17(2):189-193.
10. Omolase CO, Ogunleye OT, Omolase BO, et al. Pattern of eye diseases in a Nigerian eye hospital. S Afr Fam Pract. 2018;60(5):158-162.
11. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
12. Mactaggart I, Kuper H, Murthy GV, et al. The epidemiology of eye diseases in sub-Saharan Africa: a systematic review. Ophthalmic Epidemiol. 2016;23(6):1-17.
13. Rabiu MM, Alhassan MB, Ejere HO. Environmental sanitary interventions for preventing active trachoma. Cochrane Database Syst Rev. 2012;(2):CD004003.
14. Frick KD, Joy SM, Wilson DA, et al. The economic burden and productivity losses due to uncorrected refractive error in the United States. Optom Vis Sci. 2018;95(6):478-487.
15. Ramke J, Zwi AB, Lee L, et al. Cataract surgical coverage in low and middle-income countries: a systematic review. Ophthalmic Epidemiol. 2019;26(2):95-103.
16. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081-2090.
17. Courtright P, Mwangi N, Gichangi M, Lewallen S. Setting priorities for eye care in low-income countries. Community Eye Health. 2010;23(73):37-38.
18. O'Brien KS, Emerson P, Hooper PJ, et al. Antimicrobial resistance in the context of the SAFE strategy for trachoma control. Trans R Soc Trop Med Hyg. 2019;113(12):748-754.
19. Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017;9(9):CD004417.